What's new

EMEA-003484-PIP01-23

EMEA-003484-PIP01-23

Mar 4, 2025 0

EMEA-003484-PIP01-23

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolone, Date of authorisation: 09/02/2024, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Skyclarys, Omaveloxolo...

Human medicines European public assessment report (EPAR): Lutathera, lutetium (177Lu) oxodotreotide, Date of authorisation: 26/09/2017, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Lutathera, lutetium (1...

Human medicines European public assessment report (EPAR): Baiama, aflibercept, Date of authorisation: 13/01/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Baiama, aflibercept, D...

Human medicines European public assessment report (EPAR): Mirvaso, brimonidine, Date of authorisation: 20/02/2014, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 4, 2025 0

Human medicines European public assessment report (EPAR): Mirvaso, brimonidine, ...

PSUSA/00002943/202406

PSUSA/00002943/202406

Mar 3, 2025 0

PSUSA/00002943/202406

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 19/09/2013, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Ultibro Breezhaler, in...

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab, Date of authorisation: 25/09/2024, Revision: 1, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Fymskina, ustekinumab,...

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab, Date of authorisation: 17/08/2022, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Vegzelma, bevacizumab,...

Human medicines European public assessment report (EPAR): Clopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan), clopidogrel,acetylsalicylic acid, Date of authorisation: 09/01/2020, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Clopidogrel / Acetylsa...

Human medicines European public assessment report (EPAR): Xoterna Breezhaler, indacaterol,glycopyrronium bromide, Date of authorisation: 18/09/2013, Revision: 17, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Xoterna Breezhaler, in...

Human medicines European public assessment report (EPAR): Tecartus, Brexucabtagene autoleucel, Date of authorisation: 14/12/2020, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Tecartus, Brexucabtage...

Human medicines European public assessment report (EPAR): Anagrelide Viatris (previously Anagrelide Mylan), anagrelide, Date of authorisation: 15/02/2018, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Anagrelide Viatris (pr...

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare Professionals' (HCPWP) Working Parties joint meeting, European Medicines Agency, Amsterdam, the Netherlands, from 1 April 2025, 09:00 (CEST) to 2 April 2025, 15:50 (CEST)

European Medicines Agency (EMA) Patients' and Consumers...

Mar 3, 2025 0

European Medicines Agency (EMA) Patients' and Consumers' (PCWP) and Healthcare P...

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, Date of authorisation: 15/09/2023, Revision: 3, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Orserdu, elacestrant, ...

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetiu...

Human medicines European public assessment report (EPAR): Obodence, denosumab, Date of authorisation: 12/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Obodence, denosumab, D...

Human medicines European public assessment report (EPAR): Nepexto, etanercept, Date of authorisation: 20/05/2020, Revision: 15, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Nepexto, etanercept, D...

Regulatory Procedure Management (RPM) for the Product L...

Mar 3, 2025 0

Regulatory Procedure Management (RPM) for the Product Lifecycle Management (PLM)...

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CAPs and non-CAPs variations, Online, European Medicines Agency, Amsterdam, the Netherlands, from 6 March 2025, 11:00 (CET) to 6 March 2025, 11:30 (CET)

Q&A clinic on web-based electronic Application Form (eA...

Mar 3, 2025 0

Q&A clinic on web-based electronic Application Form (eAF) functionalities for CA...

Human medicines European public assessment report (EPAR): Beyonttra, acoramidis, Date of authorisation: 10/02/2025, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Beyonttra, acoramidis,...

Human medicines European public assessment report (EPAR): MenQuadfi, meningococcal group A, C, W-135 and Y conjugate vaccine, Date of authorisation: 18/11/2020, Revision: 20, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): MenQuadfi, meningococc...

Human medicines European public assessment report (EPAR): Spherox, spheroids of human autologous matrix-associated chondrocytes, Date of authorisation: 10/07/2017, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Spherox, spheroids of ...

Human medicines European public assessment report (EPAR): Efient, prasugrel, Date of authorisation: 24/02/2009, Revision: 27, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 3, 2025 0

Human medicines European public assessment report (EPAR): Efient, prasugrel, Dat...

34
35
36
37
38

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.